Cargando…
Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3)
Ovarian cancer incidence continues to increase at an alarming rate. Although various therapeutic approaches exist for ovarian cancer, they have limitations, including undesired side effects. Therefore, nanoparticle (NP)-mediated therapy may be a viable, biocompatible, and suitable alternative. To th...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566439/ https://www.ncbi.nlm.nih.gov/pubmed/31121951 http://dx.doi.org/10.3390/nano9050787 |
_version_ | 1783426852816158720 |
---|---|
author | Gurunathan, Sangiliyandi Qasim, Muhammad Park, Chan Hyeok Arsalan Iqbal, Muhammad Yoo, Hyunjin Hwang, Jeong Ho Uhm, Sang Jun Song, Hyuk Park, Chankyu Choi, Youngsok Kim, Jin-Hoi Hong, Kwonho |
author_facet | Gurunathan, Sangiliyandi Qasim, Muhammad Park, Chan Hyeok Arsalan Iqbal, Muhammad Yoo, Hyunjin Hwang, Jeong Ho Uhm, Sang Jun Song, Hyuk Park, Chankyu Choi, Youngsok Kim, Jin-Hoi Hong, Kwonho |
author_sort | Gurunathan, Sangiliyandi |
collection | PubMed |
description | Ovarian cancer incidence continues to increase at an alarming rate. Although various therapeutic approaches exist for ovarian cancer, they have limitations, including undesired side effects. Therefore, nanoparticle (NP)-mediated therapy may be a viable, biocompatible, and suitable alternative. To the best of our knowledge, no comprehensive analysis has been undertaken on the cytotoxicity and cellular pathways involved in ovarian cancer cells, particularly SKOV3 cells. Here, we investigated the effect of palladium NPs (PdNPs) and the molecular mechanisms and cellular pathways involved in ovarian cancer. We assayed cell viability, proliferation, cytotoxicity, oxidative stress, DNA damage, and apoptosis and performed an RNA-Seq analysis. The results showed that PdNPs elicited concentration-dependent decreases in cell viability and proliferation and induced increasing cytotoxicity at increasing concentrations, as determined by leakage of lactate dehydrogenase, increased levels of reactive oxygen species and malondialdehyde, and decreased levels of antioxidants like glutathione and superoxide dismutase. Furthermore, our study revealed that PdNPs induce mitochondrial dysfunction by altering mitochondrial membrane potential, reducing adenosine triphosphate levels, inducing DNA damage, and activating caspase 3, all of which significantly induced apoptosis in SKOV3 cells following PdNPs treatment. Gene ontology (GO) term analysis of PdNPs-exposed SKOV3 cells showed various dysregulated pathways, particularly nucleosome assembly, telomere organization, and rDNA chromatin silencing. When genes downregulated by PdNPs were applied to GO term enrichment analysis, nucleosome assembly was the top-ranked biological pathway. We also provide evidence for an association between PdNPs exposure and multiple layers of epigenetic transcriptional control and establish a molecular basis for NP-mediated apoptosis. These findings provide a foundation, potential targets, and novel insights into the mechanism underlying toxicity and pathways in SKOV3 cells, and open new avenues to identify novel targets for ovarian cancer treatment. |
format | Online Article Text |
id | pubmed-6566439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65664392019-06-17 Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3) Gurunathan, Sangiliyandi Qasim, Muhammad Park, Chan Hyeok Arsalan Iqbal, Muhammad Yoo, Hyunjin Hwang, Jeong Ho Uhm, Sang Jun Song, Hyuk Park, Chankyu Choi, Youngsok Kim, Jin-Hoi Hong, Kwonho Nanomaterials (Basel) Article Ovarian cancer incidence continues to increase at an alarming rate. Although various therapeutic approaches exist for ovarian cancer, they have limitations, including undesired side effects. Therefore, nanoparticle (NP)-mediated therapy may be a viable, biocompatible, and suitable alternative. To the best of our knowledge, no comprehensive analysis has been undertaken on the cytotoxicity and cellular pathways involved in ovarian cancer cells, particularly SKOV3 cells. Here, we investigated the effect of palladium NPs (PdNPs) and the molecular mechanisms and cellular pathways involved in ovarian cancer. We assayed cell viability, proliferation, cytotoxicity, oxidative stress, DNA damage, and apoptosis and performed an RNA-Seq analysis. The results showed that PdNPs elicited concentration-dependent decreases in cell viability and proliferation and induced increasing cytotoxicity at increasing concentrations, as determined by leakage of lactate dehydrogenase, increased levels of reactive oxygen species and malondialdehyde, and decreased levels of antioxidants like glutathione and superoxide dismutase. Furthermore, our study revealed that PdNPs induce mitochondrial dysfunction by altering mitochondrial membrane potential, reducing adenosine triphosphate levels, inducing DNA damage, and activating caspase 3, all of which significantly induced apoptosis in SKOV3 cells following PdNPs treatment. Gene ontology (GO) term analysis of PdNPs-exposed SKOV3 cells showed various dysregulated pathways, particularly nucleosome assembly, telomere organization, and rDNA chromatin silencing. When genes downregulated by PdNPs were applied to GO term enrichment analysis, nucleosome assembly was the top-ranked biological pathway. We also provide evidence for an association between PdNPs exposure and multiple layers of epigenetic transcriptional control and establish a molecular basis for NP-mediated apoptosis. These findings provide a foundation, potential targets, and novel insights into the mechanism underlying toxicity and pathways in SKOV3 cells, and open new avenues to identify novel targets for ovarian cancer treatment. MDPI 2019-05-22 /pmc/articles/PMC6566439/ /pubmed/31121951 http://dx.doi.org/10.3390/nano9050787 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gurunathan, Sangiliyandi Qasim, Muhammad Park, Chan Hyeok Arsalan Iqbal, Muhammad Yoo, Hyunjin Hwang, Jeong Ho Uhm, Sang Jun Song, Hyuk Park, Chankyu Choi, Youngsok Kim, Jin-Hoi Hong, Kwonho Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3) |
title | Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3) |
title_full | Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3) |
title_fullStr | Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3) |
title_full_unstemmed | Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3) |
title_short | Cytotoxicity and Transcriptomic Analyses of Biogenic Palladium Nanoparticles in Human Ovarian Cancer Cells (SKOV3) |
title_sort | cytotoxicity and transcriptomic analyses of biogenic palladium nanoparticles in human ovarian cancer cells (skov3) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566439/ https://www.ncbi.nlm.nih.gov/pubmed/31121951 http://dx.doi.org/10.3390/nano9050787 |
work_keys_str_mv | AT gurunathansangiliyandi cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT qasimmuhammad cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT parkchanhyeok cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT arsalaniqbalmuhammad cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT yoohyunjin cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT hwangjeongho cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT uhmsangjun cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT songhyuk cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT parkchankyu cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT choiyoungsok cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT kimjinhoi cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 AT hongkwonho cytotoxicityandtranscriptomicanalysesofbiogenicpalladiumnanoparticlesinhumanovariancancercellsskov3 |